MedPath
NMPA Approval

Nivolumab injection

国药准字SJ20245001

October 14, 2024

S20180014

Drug Information

纳武利尤单抗注射液

欧狄沃

注射剂

120mg/12ml(10mg/ml)

生物制品

October 14, 2024

March 30, 2028

Company Information

Applicant Company

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867 Ireland

Manufacturing Company

Mooswiesen 2, 88214 Ravensburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

纳武利尤单抗注射液 - NMPA 批准文号 | MedPath